Results 231 to 240 of about 17,389,371 (292)

Evaluating the effectiveness of antiseptic barrier caps in reducing central line-associated bloodstream infections in the adult ICU. [PDF]

Antimicrob Steward Healthc Epidemiol
Hussain F, Ananthanarayanan R, Niyas VKM.   +2 more
europepmc   +1 more source

Exploring virulence factors, virulome, and multidrug resistance of Klebsiella pneumoniae strains isolated from patients with central Line-associated bloodstream infections. [PDF]

Sci Rep
Sayed MG, Mansy MS, El Borhamy MI, Elsherif HM.   +3 more
europepmc   +1 more source

Racial disparities in central line-associated bloodstream infections: the impact of the COVID-19 pandemic. [PDF]

Infect Control Hosp Epidemiol
DeWitt ME, Sampson MM, Kester S, MacNeill E, Passaretti C.   +4 more
europepmc   +1 more source

A Systematic Review of Length of Stay Linked to Hospital-Acquired Falls, Pressure Ulcers, Central Line-Associated Bloodstream Infections, and Surgical Site Infections. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Hasan B, Bechenati D, Bethel HM, Cho S, Rajjoub NS, Murad ST, Kabbara Allababidi A, Rajjo TI, Yousufuddin M.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Central line associated and primary bloodstream infections

Current Opinion in Critical Care, 2023
Purpose of review Primary and intravascular catheter-associated bloodstream infections (CA-BSIs) represent an important clinical entity in the intensive care unit (ICU) being associated with significant morbidity and mortality. The purpose of this review was to examine the recently published data on epidemiology and management ...
Stewart, Adam G., Laupland, Kevin B., Tabah, Alexis   +2 more
openaire   +5 more sources

Elimination of Central Line–associated Bloodstream Infections

AACN Advanced Critical Care, 2006
Central line-associated bloodstream infections are considered to be an avoidable complication of care delivery. In addition to considerable morbidity and use of resources, central line-associated bloodstream infections carry an attributable morality between 12% and 25%. The estimated cost per infection is approximately 25,000 US dollars.
Patricia J, Posa, Denise, Harrison, Kathleen M, Vollman   +2 more
  +5 more sources